Back to search
FDAFDA · Food and drugs·Recall number D-0875-2026

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

Published October 7, 2026 · Recall initiated: August 31, 2026

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
ZOLADEX
Manufacturer
TerSera Therapeutics LLC
Distributor
USA Nationwide
Lot
Lot#: YN0099, Exp 01/31/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36. recalled?

Yes. FDA published recall D-0875-2026 on October 7, 2026. Reported hazard: Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ZOLADEX.

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Recalert also tracks expiration dates so you can sell stock before it becomes a loss.

Check your inventory (free)